Covid-19 roundup: Mod­er­na inks fill-fin­ish pact with Sam­sung Bi­o­log­ics; So­ri­ot dis­cuss­es vac­cine woes, says shot 'has a fu­ture' — re­port

As Mod­er­na has ramped up its man­u­fac­tur­ing ca­pa­bil­i­ties and looks to dis­trib­ute its vac­cine dos­es to coun­tries in dire need, the com­pa­ny has inked a deal with South Ko­re­an CD­MO Sam­sung Bi­o­log­ics for fill-fin­ish du­ties.

Sam­sung’s pro­duc­tion line in In­cheon will sup­port the pro­duc­tion of 100s of mil­lions of dos­es, good for dis­tri­b­u­tion at the start of Q3. Ko­rea has se­cured 40 mil­lion dos­es of the vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER